ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Align Technology Opens 2025 Annual Research Program to Advance Orthodontic and Dental Patient Care

2025 Grant Application Process Now Open for Up to $300,000 in Funding

Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2025 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology’s Research Award Program has funded approximately $3.75 million in research since the program’s inception in 2010.

“This program continues to generate much scientific and clinical interest from university researchers around the globe to further expand the quality of treatment outcomes and patient care as well as biology of tooth movement with clear aligners,” said Dr. Mitra Derakhshan, Align executive vice president, chief clinical officer. “We look forward to the reviewing the wide variety of applications from researchers focused on advancing the field of dental science.”

“The topics submitted throughout the past years have been diverse and often on the forefront of the dental field,” said John Morton, Align vice president, product innovation and technical fellow. “Align Technology is proud to fund this research program with the purpose of improving dental care throughout the world.”

Awards available for dental research at universities are available in the following regions:

  • Americas (US, Canada, Mexico, Central and South America): Four one-year awards of up to US$25,000 each
  • EMEA: Four one-year awards of up to US$25,000 each
  • APAC: Four one-year awards of up to US$25,000 each

Eligible applicants for dental research awards include full-time and part-time faculty involved in dental or scientific research at universities where Invisalign® treatment or the iTero™ scanner is available. All applications are reviewed by an independent academic committee that then forwards its recommendations to Align for final selection. Program details, instructions, and application forms for prospective applicants can be found at https://learn.aligntech.com/pages/61/resources (for Americas, EMEA and APAC applicants). Research proposals and completed applications must be received by 5:00 p.m. Pacific Time on March 7, 2025. Award recipients will be notified by June 2, 2025.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 271 thousand doctor customers and is key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 27 years, Align has helped doctors approximately 18.9 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.